ScreenPoint Medical’s Transpara Breast AI Suite Joins Ferrum Health’s Model Hub to Support Scalable, Trusted AI Deployment

ScreenPoint Medical, known for its expertise in breast imaging AI, has announced that its Transpara Breast AI Suite is now available on Ferrum Health’s Model Hub. The suite includes Detection, Density, and Temporal Comparison tools designed to assist radiologists in the early detection of breast cancer and reduction of reading workload for both 2D and 3D mammography exams.

Transpara’s integration into Ferrum Health’s platform represents a strategic alignment between clinically validated AI technology and an enterprise-wide governance solution. Ferrum Health’s AI Governance Suite is built specifically for health systems looking to move beyond piecemeal AI deployments. Through its Model Hub, organizations gain a centralized foundation to deploy, manage, and evaluate AI across departments—while maintaining control over data, privacy, and performance validation.

"ScreenPoint's Transpara Breast AI is one of the most clinically validated breast AI solutions in the world, and its availability on Ferrum's Model Hub reflects what health systems are demanding right now: proven performance, real-world scale, and trust," said Peter Eason, COO of Ferrum Health. “By bringing Transpara's Detection, Density, and Temporal Comparison capabilities into a governed, integrated environment, we're helping radiology teams adopt AI with confidence while advancing earlier detection and more equitable screening outcomes.”

Transpara has been widely adopted by leading healthcare organizations across the globe. Its detection tool remains the only breast AI solution validated in a randomized controlled trial, with peer-reviewed research demonstrating up to a 29% improvement in cancer detection rates—regardless of breast density, patient ethnicity, or radiologist experience.

The addition of Transpara to Ferrum’s Model Hub also offers healthcare systems the ability to validate the algorithm against their own local data before full clinical implementation. This approach streamlines the safe integration of AI into existing workflows while helping organizations monitor outcomes and performance over time.

"Ferrum Health's platform creates a seamless and integrated AI workflow to facilitate the future of care," said Albert Gubern-Mérida, Chief Product and Technology Officer at ScreenPoint Medical. "Modern workflows rely on the best available algorithms. We are proud to bring Transpara's industry-leading performance to leading hospital systems in the service of their patients, their providers, and their populations."

This partnership reflects growing demand from radiology departments for scalable, trustworthy AI tools that integrate efficiently into clinical environments while delivering measurable value. Through Ferrum Health’s infrastructure, Transpara Breast AI can be deployed with oversight, ensuring it meets the high clinical standards expected by health systems and their care teams.